StonvexLoading…
StonvexStonvexStonvexCore line items from STE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $5.46B | $5.14B | $1.30B | $1.24B |
Operating Income | $866.64M | $836.12M | $189.60M | $155.85M |
Net Income | $614.64M | $378.24M | $140.74M | $115.32M |
EPS (Diluted) | $6.20 | $3.81 | $1.42 | $1.16 |
Total Assets | $10.15B | $11.06B | Not available | Not available |
Total Liabilities | $3.53B | $4.75B | Not available | Not available |
Cash & Equivalents | $171.70M | $207.02M | Not available | Not available |
Free Cash Flow OCF − CapEx | $778.00M | $612.95M | Not available | Not available |
Shares Outstanding | 98.30M | 98.88M | Not available | Not available |